Durect Corp (STU:DC8A)
€ 0.81 0 (0%) Market Cap: 27.64 Mil Enterprise Value: 30.87 Mil PE Ratio: 0 PB Ratio: 24.82 GF Score: 49/100

Q4 2023 DURECT Corp Earnings Call Transcript

Mar 27, 2024 / 08:30PM GMT
Release Date Price: €1.21 (+6.14%)
Operator

Greetings and welcome to the DURECT Corp fourth-quarter and full-year earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Tim Papp, Chief Financial Officer. Thank you. Tim, you may begin.

Tim Papp
DURECT Corp - Chief Financial Officer

Good afternoon and welcome to direct Corporation's Fourth Quarter 2023 earnings conference call business. Tim Taft Chief Financial Officer of Darex.

Before we begin, I would like to remind you of our Safe Harbor statements. During the course of this call, we may make forward-looking statements regarding direct products and development, expected product benefits, our development plans, future clinical trials or projected financial results. These forward-looking statements involve risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. For further information regarding these and other risks can be found in our SEC filings, including our 10 K and 10 Q under the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot